Search Results - "Devarakonda, Krishna R."

Refine Results
  1. 1
  2. 2

    Pulmonary toxicity assessment of multiwalled carbon nanotubes in rats following intratracheal instillation by Reddy, A. Rama Narsimha, Reddy, Y. Narsimha, Krishna, Devarakonda R., Himabindu, V.

    Published in Environmental toxicology (01-03-2012)
    “…In this study, we have evaluated the pulmonary toxicity of intratracheally (i.t.) instilled two multi walled carbon nanotubes (MWCNT) in rats. The lungs of…”
    Get full text
    Journal Article
  3. 3

    An improved synthesis of lysosomal activated mustard prodrug for tumor-specific activation and its cytotoxic evaluation by Adidala, Raghuramreddy, Devalapally, Harikrishna, Srivari, Chandrasekhar, Devarakonda R, Krishna, Raghuram Rao, Akkinepally

    Published in Drug development and industrial pharmacy (01-09-2012)
    “…Cyclophosphamide, an alkylating agent widely used as anticancer agent, biotransformed in vivo to unstable phosphoramidic mustard and acrolein, where the latter…”
    Get full text
    Journal Article
  4. 4

    Translocation and extra pulmonary toxicities of multi wall carbon nanotubes in rats by Rama Narsimha Reddy, A., Krishna, Devarakonda R., Narsimha Reddy, Y., Himabindu, V.

    Published in Toxicology mechanisms and methods (01-06-2010)
    “…This study evaluated the ability of the multi wall carbon nanotubes (MWCNT) to induce extra pulmonary toxicities in rats following intra-tracheal (IT)…”
    Get full text
    Journal Article
  5. 5

    In vitro binding and receptor-mediated activity of terlipressin at vasopressin receptors V1 and V2 by Jamil, Khurram, Pappas, Stephen Chris, Devarakonda, Krishna R

    “…Terlipressin, a synthetic, systemic vasoconstrictor with selective activity at ­vasopressin-1 (V1) receptors, is a pro-drug for the endogenous/natural porcine…”
    Get full text
    Journal Article
  6. 6

    Diosmin pretreatment affects bioavailability of metronidazole by RAJNARAYANA, K, REDDY, Mada S, KRISHNA, Devarakonda R

    Published in European journal of clinical pharmacology (01-04-2003)
    “…To screen for inhibitory effects of diosmin on cytochrome P(450)-mediated metabolism of metronidazole in healthy volunteers. Before/after non-blinded…”
    Get full text
    Journal Article
  7. 7

    Evaluation of oxidative stress and anti-oxidant status in rat serum following exposure of carbon nanotubes by Reddy, A. Rama Narsimha, Rao, M. Venkateswar, Krishna, Devarakonda R., Himabindu, V., Reddy, Y. Narsimha

    Published in Regulatory toxicology and pharmacology (01-03-2011)
    “…The aim of the present study was to evaluate the oxidative stress and anti-oxidant status in rat serum following intra-tracheal instillation of multi wall…”
    Get full text
    Journal Article
  8. 8

    Oxidative biomarkers to assess the nanoparticle-induced oxidative stress by Anreddy, Rama Narsimha Reddy, Yellu, Narsimha Reddy, Devarakonda, Krishna R

    “…Nanotechnology involves the creation and manipulation of materials at nanoscale levels to create products that exhibit novel properties. Engineered…”
    Get more information
    Journal Article
  9. 9

    Predictive models for drugs exhibiting negative food effects based on their biopharmaceutical characteristics by Marasanapalle, Venugopal P., Crison, John R., Devarakonda, Krishna R., Li, Xiaoling, Jasti, Bhaskara R.

    Published in Drug development and industrial pharmacy (01-12-2011)
    “…Context: A drug is defined to exhibit food effects if its pharmacokinetic parameter, area under the curve (AUC0-∞) is different when co-administered with food…”
    Get full text
    Journal Article
  10. 10

    Does pH 6 β-galactosidase activity indicate cell senescence? by Krishna, Devarakonda R, Sperker, Bernhard, Fritz, Peter, Klotz, Ulrich

    Published in Mechanisms of ageing and development (30-08-1999)
    “…Apparently two forms of β-galactosidase (β-GAL) in cells or tissue sections can be detected by enzyme histochemical staining (X-GAL). Using a sensitive and…”
    Get full text
    Journal Article
  11. 11

    Cardiovascular risk among university students from developed and developing nations by Bleske, Barry E, Erickson, Steven R, Fahoum, Sahar, Devarakonda, Krishna R, Welage, Lynda S, Koudmani, Marah, Pantham, Narayan, Edwin, Stephanie B, Devarakonda, Siddhartha, Shea, Michael J, Martha, Srinivas, Khalidi, Nabil

    Published in The open cardiovascular medicine journal (01-01-2011)
    “…A key aspect in halting global increase in cardiovascular events is prevention and especially prevention at an early age. Unfortunately, global data regarding…”
    Get full text
    Journal Article
  12. 12

    In vitro binding and receptor-mediated activity of terlipressin at vasopressin receptors [V.sub.1] and [V.sub.2] by Jamil, Khurram, Pappas, Stephen Chris, Devarakonda, Krishna R

    Published in Journal of experimental pharmacology (01-01-2018)
    “…Terlipressin, a synthetic, systemic vasoconstrictor with selective activity at vasopressin-1 ([V.sub.1]) receptors, is a pro-drug for the endogenous/natural…”
    Get full text
    Journal Article
  13. 13

    In vitro binding and receptor-mediated activity of terlipressin at vasopressin receptors V 1 and V 2 by Jamil, Khurram, Pappas, Stephen Chris, Devarakonda, Krishna R

    “…Terlipressin, a synthetic, systemic vasoconstrictor with selective activity at vasopressin-1 (V ) receptors, is a pro-drug for the endogenous/natural porcine…”
    Get full text
    Journal Article
  14. 14

    Bioavailability of diclofenac sodium after pretreatment with diosmin in healthy volunteers by Rajnarayana, K, Venkatesham, A, Krishna, Devarakonda R

    “…Diclofenac sodium is a non-steroidal anti-inflammatory drug (NSAID). It undergoes extensive Phase I and Phase II metabolism and in vitro it is a specific…”
    Get more information
    Journal Article
  15. 15

    Influence of some bioflavonoids on the transport of nitrendipine by Rajnarayana, Kandhagatla, Venkatesham, Allenki, Krishna, Devarakonda R

    “…Flavonoids form a large class of phenolic substances widely distributed in nature and exhibit several biological effects. P-glycoprotein is part of a large…”
    Get more information
    Journal Article
  16. 16

    Study on the Influence of Silymarin Pretreatment on Metabolism and Disposition of Metronidazole by Rajnarayana, Kandhagatla, Reddy, Mada Sripal, Vidyasagar, Jenugu, Krishna, Devarakonda R.

    Published in Arzneimittel-Forschung (01-01-2004)
    “…Summary A clinical study was undertaken in 12 healthy volunteers. At first, subjects received metronidazole (CAS 443-48-1; a substrate for cytochrome CYP3A4…”
    Get full text
    Journal Article
  17. 17

    Extrahepatic metabolism of drugs in humans by KRISHNA, D. R, KLOTZ, U

    Published in Clinical pharmacokinetics (01-02-1994)
    “…Although the liver plays the major role in drug metabolism [e.g. by oxidative cytochrome P450 (CYP)-dependent phase I and conjugation or phase II reactions],…”
    Get full text
    Journal Article
  18. 18

    Synthesis and Evaluation of Anticancer Activity of Some Imidazothiazolyl, Imidazobenzothiazolyl and Dihydroimidazothiazolyl Coumarins by Srimanth, Kagne, Rao, Vedula Rajeswar, Krishna, Devarakonda R.

    Published in Arzneimittel-Forschung (01-01-2002)
    “…Summary A series of 6-(2H-1-benzopyran-2-one-3-yl)imidazo[2,1-b]thiazoles (1) , 2-(2H-1-benzopyran-2-one-3-yl)imidazo[2,1-b]benzothiazoles (2) and…”
    Get full text
    Journal Article
  19. 19

    Determination of Antioxidant Activity of Some Drugs Using High-pressure Liquid Chromatography by Karunakar, Neelam, Prabhakar, Marsanapalle C., Krishna, Devarakonda R.

    Published in Arzneimittel-Forschung (01-01-2003)
    “…Summary The antioxidant activities of different drugs like acetylsalicylic acid, nimesulide, dapsone, methlydopa, rifampicin and the well known antioxidants…”
    Get full text
    Journal Article
  20. 20

    Differential expression of dipeptidyl peptidase-IV (DPP-IV) in Indian type-2 diabetic population by Venkatesham, Allenki, Srinivas, Martha, Krishna, Devarakonda R, Narayana, Pantam

    “…Dipeptidyl peptidase IV (CD26; E.C. 3.4.14.5) is plasma membrane glycoprotein exopeptidase. There are no data on both phenotypic or genotypic expression and…”
    Get full text
    Journal Article